Trends in

Anti-Bacterial Agents / therapeutic use Clarithromycin / therapeutic use Drug Resistance, Bacterial / genetics Genome, Bacterial Genomics Helicobacter Infections / drug therapy Helicobacter pylori / genetics High-Throughput Nucleotide Sequencing Phenotype RNA, Ribosomal, 23S
23S ribosomal RNA subunit Helicobacter pylori clarithromycin next-generation sequencing point mutations resistance

Journal

Microbial genomics
ISSN: 2057-5858
Titre abrégé: Microb Genom
Pays: England
ID NLM: 101671820

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 3 3 2020
medline: 15 12 2020
entrez: 3 3 2020
Statut: ppublish

Résumé

For a long time

Identifiants

DOI: 10.1099/mgen.0.000344 PMID: 32118532 PMC: PMC7200067
pubmed: 32118532
doi: 10.1099/mgen.0.000344
pmc: PMC7200067
doi:

Substances chimiques

Anti-Bacterial Agents 0
RNA, Ribosomal, 23S 0
Clarithromycin H1250JIK0A

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nucleic Acids Res. 2019 Jan 8;47(D1):D1102-D1109
pubmed: 30371825
Antimicrob Agents Chemother. 2002 Dec;46(12):3765-9
pubmed: 12435674
Antimicrob Agents Chemother. 2002 Apr;46(4):1156-7
pubmed: 11897613
J Clin Microbiol. 2010 Oct;48(10):3703-7
pubmed: 20668128
Front Microbiol. 2013 Feb 05;4:7
pubmed: 23386844
Mem Inst Oswaldo Cruz. 2010 May;105(3):314-7
pubmed: 20512246
Cold Spring Harb Perspect Biol. 2012 May 01;4(5):
pubmed: 20739415
Gut. 1999 Apr;44(4):463-7
pubmed: 10075951
J Antimicrob Chemother. 1985 Jul;16 Suppl A:23-34
pubmed: 3932309
World J Gastroenterol. 2008 Sep 7;14(33):5217-22
pubmed: 18777600
J Bacteriol. 2006 Jan;188(1):249-54
pubmed: 16352841
Antimicrob Agents Chemother. 1985 Nov;28(5):630-3
pubmed: 4091529
J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S75-9
pubmed: 20586871
Turk J Gastroenterol. 2013;24(1):5-9
pubmed: 23794337
J Microbiol Biotechnol. 2008 Sep;18(9):1584-9
pubmed: 18852516
Diagn Microbiol Infect Dis. 1996 Jan;24(1):37-41
pubmed: 8988762
Gut Microbes. 2013 Nov-Dec;4(6):541-8
pubmed: 23929066
Adv Biomed Res. 2014 Mar 25;3:98
pubmed: 24800187
Helicobacter. 2007 Oct;12(5):505-9
pubmed: 17760718
Antimicrob Agents Chemother. 1999 Jul;43(7):1779-82
pubmed: 10390244
Eur J Clin Microbiol Infect Dis. 2002 Jul;21(7):549-52
pubmed: 12172749
Trends Microbiol. 2001 Feb;9(2):71-9
pubmed: 11173246
Ann Clin Microbiol Antimicrob. 2003 Nov 21;2:11
pubmed: 14633281
Antimicrob Agents Chemother. 2000 Feb;44(2):248-54
pubmed: 10639345
Antimicrob Agents Chemother. 1997 Nov;41(11):2550-3
pubmed: 9371366
World J Gastroenterol. 2014 May 21;20(19):5594-609
pubmed: 24914319
Gut Pathog. 2014 Jun 26;6:27
pubmed: 24995043
Arq Gastroenterol. 2016 Oct-Dec;53(4):215-223
pubmed: 27706449
Antimicrob Agents Chemother. 1997 Dec;41(12):2621-8
pubmed: 9420030
Helicobacter. 2009 Feb;14(1):22-8
pubmed: 19191892
mBio. 2017 Feb 21;8(1):
pubmed: 28223462
Infect Drug Resist. 2019 Mar 04;12:535-543
pubmed: 30881059
World J Gastroenterol. 2018 Apr 14;24(14):1531-1539
pubmed: 29662291
J Biomol Screen. 2005 Apr;10(3):235-45
pubmed: 15809319
Antimicrob Agents Chemother. 2001 May;45(5):1500-4
pubmed: 11302817
J Microbiol. 2013 Oct;51(5):612-8
pubmed: 24173641
Int J Antimicrob Agents. 2015 Mar;45(3):244-8
pubmed: 25499186
Infect Drug Resist. 2019 Mar 12;12:597-602
pubmed: 30881065
Archaea. 2013;2013:614735
pubmed: 23554567
J Med Microbiol. 2019 Apr;68(4):566-573
pubmed: 30724729
J Clin Microbiol. 2013 Jun;51(6):1887-93
pubmed: 23596234
J Clin Microbiol. 1998 Nov;36(11):3285-90
pubmed: 9774580
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28242673
Cold Spring Harb Perspect Med. 2016 Sep 01;6(9):
pubmed: 27481773
Microb Drug Resist. 2017 Apr;23(3):351-358
pubmed: 27391421
J Clin Microbiol. 2000 Jan;38(1):210-4
pubmed: 10618089
World J Gastroenterol. 2004 Apr 1;10(7):1075-7
pubmed: 15052698
J Clin Microbiol. 2018 Aug 27;56(9):
pubmed: 29925646
Mol Microbiol. 1994 Feb;11(3):509-23
pubmed: 8152375
J Antimicrob Chemother. 1997 Aug;40(2):283-6
pubmed: 9301997
J Med Microbiol. 2014 Mar;63(Pt 3):453-457
pubmed: 24344205
FEMS Microbiol Lett. 1997 Mar 1;148(1):63-8
pubmed: 9066112
Gut. 2017 Jan;66(1):6-30
pubmed: 27707777
Gut. 2004 Sep;53(9):1374-84
pubmed: 15306603
Biomed Res Int. 2018 Sep 10;2018:2684836
pubmed: 30276203
Antimicrob Agents Chemother. 2008 Sep;52(9):3465-6
pubmed: 18606842
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Front Microbiol. 2018 Dec 18;9:3154
pubmed: 30619218
Antimicrob Agents Chemother. 1997 Mar;41(3):712-4
pubmed: 9056021
Antimicrob Agents Chemother. 2004 Sep;48(9):3567-9
pubmed: 15328128
Antimicrob Agents Chemother. 1997 Dec;41(12):2724-8
pubmed: 9420046
PLoS Genet. 2010 Aug 19;6(8):e1001069
pubmed: 20808891
J Clin Microbiol. 2003 Jan;41(1):397-402
pubmed: 12517879
Mol Microbiol. 1995 Apr;16(1):45-55
pubmed: 7651136
Clin Microbiol Infect. 2016 Nov;22(11):922-927
pubmed: 27451940
J Clin Med. 2019 Jan 07;8(1):
pubmed: 30621024
Trends Biochem Sci. 2018 Sep;43(9):668-684
pubmed: 30054232
Antimicrob Agents Chemother. 1998 Aug;42(8):1952-8
pubmed: 9687389
Helicobacter. 1996 Dec;1(4):227-8
pubmed: 9432314
Helicobacter. 2004 Oct;9(5):396-9
pubmed: 15361077
J Clin Microbiol. 2008 Jul;46(7):2320-6
pubmed: 18463216
Antimicrob Agents Chemother. 1996 Feb;40(2):477-80
pubmed: 8834903
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Glob Antimicrob Resist. 2019 Mar;16:87-91
pubmed: 30266639
Medicine (Baltimore). 2018 Aug;97(33):e11835
pubmed: 30113472
J Clin Microbiol. 2019 Jun 25;57(7):
pubmed: 31068413
Nat Commun. 2014 Jun 13;5:4165
pubmed: 24924186
Int J Antimicrob Agents. 2004 Apr;23(4):349-55
pubmed: 15081083
BMC Bioinformatics. 2002;3:2
pubmed: 11869452
J Clin Microbiol. 1997 Jul;35(7):1842-6
pubmed: 9196205
Aliment Pharmacol Ther. 2002 Feb;16(2):167-80
pubmed: 11860399
Antimicrob Agents Chemother. 1994 Jul;38(7):1496-500
pubmed: 7979278
J Clin Microbiol. 1995 Apr;33(4):1028-30
pubmed: 7790430
Antimicrob Agents Chemother. 2005 Apr;49(4):1477-82
pubmed: 15793129
Gut Liver. 2018 Nov 15;12(6):641-647
pubmed: 30037168
F1000Res. 2016 Apr 13;5:671
pubmed: 27583131
J Korean Med Sci. 2002 Oct;17(5):599-603
pubmed: 12378008
J Clin Microbiol. 2009 Nov;47(11):3600-7
pubmed: 19759218
PLoS Comput Biol. 2014 Dec 04;10(12):e1003998
pubmed: 25474019
RNA. 2013 Feb;19(2):158-66
pubmed: 23249745
Antimicrob Agents Chemother. 2001 Jan;45(1):1-12
pubmed: 11120937

Auteurs

Andreia T Marques (AT)

Host-Pathogen Interactions Unit, Research Institute for Medicines (iMed-ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.

Jorge M B Vítor (JMB)

Department of Biochemistry and Human Biology, Faculty of Pharmacy, Universidade de Lisboa, 1649 003 Lisbon, Portugal.
Host-Pathogen Interactions Unit, Research Institute for Medicines (iMed-ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.

Andrea Santos (A)

National Reference Laboratory for Gastrointestinal Infections, Department of Infectious Diseases, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.

Mónica Oleastro (M)

National Reference Laboratory for Gastrointestinal Infections, Department of Infectious Diseases, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.

Filipa F Vale (FF)

Host-Pathogen Interactions Unit, Research Institute for Medicines (iMed-ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Management of the infected total elbow arthroplasty.

Joaquin Sanchez-Sotelo
1.00
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Fasciola hepatica and Fasciola hybrid form co-existence in yak from Tibet of China: application of rDNA internal transcribed spacer.

Wenqiang Tang, Yule Zhou, Leyi Li et al.
1.00
Animals Cattle Tibet Fasciola Fascioliasis

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Trends in
questionsmedicales.fr › Composés chimiques organiques › Lactones › Érythromycine › Clarithromycine › Trends in
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Trends in
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Génome microbien › Génome bactérien › Trends in
questionsmedicales.fr › Disciplines des sciences naturelles › Disciplines des sciences biologiques › Biologie › Génétique › Génomique › Trends in
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Helicobacter › Trends in
questionsmedicales.fr › Bactéries › Proteobacteria › Epsilonproteobacteria › Campylobacterales › Helicobacteraceae › Helicobacter › Helicobacter pylori › Trends in
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Trends in
questionsmedicales.fr › Phénomènes génétiques › Phénotype › Trends in
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN ribosomique › ARN ribosomique 23S › Trends in